CLINICAL_TRIALS
trial_result
· 2010-09-13
Clinical Trial Update: Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia [Phase 2]
Summary
Phase 2 trial evaluating teriparatide (Forteo) for postoperative hypocalcemia was terminated. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Hypocalcemia | Phase 2 | Status: TERMINATED | Results posted: 2010-09-13